OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
The Eur J Extracellular Vesicles
Open-access
Submit a manuscript

By

admin
EDITORIAL ISSN: 0000-0000 EJEV (2020), Vol 1, in press Published online: 01 April 2020 Full Text (Sohail ~227kb) Muhammad Sohail* St Hilda’s College, Cowley Place, University of Oxford, Oxford OX4 1DY, UK *Correspondence to: Muhammad Sohail, Email: muhammad.sohail@st-hildas.ox.ac.uk © Copyright The Author(s). This is an open access article, published under the terms of the Creative Commons...
Read More
METHOD ISSN: 2514-3247 Aptamers (2019), Vol 3, 10-16 Published online: 20 December 2019 Full Text Access Zhesen Tan, Trevor A Feagin, Jennifer M Heemstra* Department of Chemistry, Emory University, Atlanta, Georgia, USA *Correspondence to: Jennifer Heemstra, Email: jen.heemstra@emory.edu, Tel: + 404 727 7766 Received: 15 June 2019 | Revised: 05 December 2019 | Accepted: 06 December 2019 ©...
Read More
TECHNICAL REPORT ISSN: 2514-3247 Aptamers (2019), Vol 3, 04-09 Published online: 23 November 2019 Full Text Access Justin Henri 1, Narges Bayat 3, 4, Joanna Macdonald 1, 2, and Sarah Shigdar 1,2,* 1 School of Medicine Deakin University, Geelong, Victoria 3128, Australia 2 Centre for Molecular and Medical Research, Deakin University, Geelong, Victoria, 3216, Australia 3...
Read More
We are delighted and honoured that Professor Larry Gold will deliver a keynote address at Aptamers 2020. He will also receive a Lifetime Achievement Award on behalf of the International Society on Aptamers (INSOAP) for is pioneering and extraordinary contributions to the field of aptamers and therapeutics. Dr Larry Gold is the Founder and Chairman...
Read More
We are delighted to announce that Dr Nebojsa Janjic will chair Aptamers 2020. Dr Nebojsa Janjic is the Chief Science Officer at SomaLogic. Prior to joining SomaLogic, Dr Janjic was the CSO at Replidyne, Inc, a biotechnology company focusing on the development of small-molecule antibacterial agents. Prior to Replidyne, he was Senior Director of Drug Discovery...
Read More
MEETING REVIEW ISSN: 2514-3247 Aptamers (2019), Vol 3, 01-03 Published online: 14 July 2019 Full Text Access Sarah Shigdar 1,2, Philip Johnson 3, Georg Pietruschka 4, Tjaša Legen 4, Günter Mayer 4, Maureen McKeague 5,6 1 School of Medicine Deakin University, Geelong, Victoria 3128, Australia 2 Centre for Molecular and Medical Research, Deakin University, Geelong, Victoria...
Read More
The INSOAP’s Aptamers meeting has been running at Oxford since 2014, and has attracted attendance from several key scientists in the field, industry researchers, solution providers, and young and emerging researchers. We are now inviting proposals for chairing the 2020 meeting. If you are interested in chairing it, or would like to suggest a chair,...
Read More
Fee Structure Early bird and group discounts are available. Register 3 for the price of 2 until 31 December 2019 (cheapest registration free – Promocode: 3for2)* Register 4 for the price of 3 any time (cheapest registration free – Promocode: 4for3)* Fees apply to payments made on or before the indicated deadlines and not to...
Read More
TAGCyx Biotechnologies Inc. is a drug discovery and development company based in Japan, spun out of Riken Research Institute. We utilizes its proprietary, artificial nucleotide base pair technology invented by Dr. Ichiro Hirao to generate unique DNA aptamer, Xenoligo®, for therapeutic purposes.  Amongst various type of aptamers, the advantage of Xenoligo® are: 1) comprised of DNA,...
Read More
1 2 3 4 10

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases